Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis

Memorias do Instituto Oswaldo Cruz

Volumn 109, Issue 2, 2014, Pages 202-209

  Dantas, Marina Loyola ^a   de Oliveira, Juliana Menezes Gomes Cabral ^a   Carvalho, Lucas ^b,c   Passos, Sara Timóteo ^b,c   Queiroz, Adriano ^b,c   Guimarães, Luiz Henrique ^b,c   Machado, Paulo ^b,c   Carvalho, Edgar ^b,c   Arruda, Sérgio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Instituto Nacional de Ciencia e Tecnologia de Doencas Tropicais   (Brazil)

Author keywords

Disseminated leishmaniasis; Histopathological aspects; Inflammation; Inflammatory cells; Leishmaniasis

Indexed keywords

EOSIN; HEMATOXYLIN; LEISHMANIN; PARASITE ANTIGEN;

ADOLESCENT; ADULT; B LYMPHOCYTE; BIOPSY; DERMIS; DISEASE COURSE; EPIDERMIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MALE; MIDDLE AGED; NEUTROPHIL; PARASITOLOGY; PATHOLOGY; PLASMA CELL; SKIN; SKIN LEISHMANIASIS; SKIN ULCER; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; BIOPSY; DERMIS; DISEASE PROGRESSION; EOSINE YELLOWISH-(YS); EPIDERMIS; FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, DIFFUSE CUTANEOUS; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PLASMA CELLS; SKIN; SKIN ULCER; YOUNG ADULT;

EID: 84897855003     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276130312     Document Type: Article

References (44)

1. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, dos Reis G, Dutra AN, Clarêncio J, de Oliveira CI, Barral A, Barral-Netto M, Brodskyn CI 2008. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol 84: 389-396.
2. Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, Müller K, Solbach W, Laskay T 2002. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 169: 898-905.
3. Antonelli LRV, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ 2005. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101: 226-230.
4. Ashford RW, Desjeux P, Deraadt P 1992. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 8: 104-105.
5. Azulay RD 1960. Histopatologia da leishmaniose tegumentar. Dermatol Iber Lat Am 2: 7-15.
6. Campanelli AP, Roselino AM, Cavassani K, Pereira MSF, Mortara R, Brodskyn CI, Goncalves HS, Belkaid Y, Barral-Netto M, Barral A, Silva JS 2006. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313-1322.
7. Carter NA, Rosser EC, Mauri C 2012. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther 14: R32.
8. Carvalho EM, Barral A, Costa JM, Bittencourt A, Marsden P 1994. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop 56: 315-325.
9. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JL, Reed S, Rocha H 1985. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 135: 4144-4148.
10. Costa JM, Marsden PD, Llanos-Cuentas EA, Netto EM, Carvalho EM, Barral A, Rosa AC, Cuba CC, Magalhães AV, Barreto AC 1986. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J Trop Med Hyg 89: 319-323.
11. Coutinho SG, Oliveira MP, da-Cruz AM, de Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D 1996. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp Parasitol 84: 144-155.
12. Daboul MW 2010. Role of neutrophils in cutaneous leishmaniasis. East Mediterr Health J 16: 1055-1058.
13. da-Cruz AM, Bertho AL, Oliveira-Neto MP, Coutinho SG 2005. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 153: 537-543.
14. da-Cruz AM, Conceição-Silva F, Bertho AL, Coutinho SG 1994. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 62: 2614-2618.
15. Diaz NL, Zerpa O, Ponce LV, Convit J, Rondon AJ, Tapia FJ 2002. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol 11: 34-41.
16. Esterre P, Dedet JP, Frenay C, Chevallier M, Grimaud JA 1992. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 421: 239-247.
17. Giannoukakis N, Trucco M 2012. A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 19: 279-287.
18. Gollob KJ, Antonelli LRV, Dutra WO 2005. Insights into CD4+ memory T cells following Leishmania infection. Trends Parasitol 21: 347-350.
19. Guimarães LH, Machado PRL, Lessa HA, Lessa M, D'Oliveira A, Carvalho EM 2005. Aspectos clínicos da leishmaniose tegumentar. Gaz méd Bahia 75: 66-74.
20. Laskay T, van Zandbergen G, Solbach W 2003. Neutrophil granulocytes-Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol 11: 210-214.
21. Machado PR, Rosa MEA, Costa D, Mignac M, Silva JS, Schriefer A, Teixeira MM, Bacellar O, Carvalho EM 2011. Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response. Trans R Soc Trop Med Hyg 105: 438-444.
22. Magalhães AV, Chiarini LH, Raick AN 1982. Histopathology of cutaneous leishmaniasis. Rev Inst Med Trop Sao Paulo 24: 268-276.
23. Magalhães AV, Moraes MAP, Raick AN, Cuentas AL, Costa JML, Cuba CC, Marsden PD 1986. Histopathology of tegumentary leishmaniasis caused by Leishmania braziliensis braziliensis. 2. Tissue humoral response. Rev Inst Med Trop Sao Paulo 28: 293-299.
24. McSorley S, Proudfoot L, O'Donnell CA, Liew FY 1996. Immunology of murine leishmaniasis. Clin Dermatol 14: 451-464.
25. Mehregan DR, Mehregan AH, Mehregan DA 1999. Histologic diagnosis of cutaneous leishmaniasis. Clin Dermatol 17: 297-304.
26. Milon G, Giudice GD, Louis JA 1995. Immunobiology of experimental cutaneous leishmaniasis. Parasitol Today 11: 244-247.
27. MS-Ministério da Saúde Brasil 2007. Leishmaniose tegumentar americana. Portal da Saúde. Available from: portal. saude. gov. br/portal/saude/profissional/area. cfm?id_area=1560.
28. Müller I, Kropf P, Louis JA, Milon G 1994. Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major. Infect Immun 62: 2575-2581.
29. Müller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, Solbach W, Laskay T 2001. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol 190: 73-76.
30. Palma GI, Saravia NG 1997. In situ characterization of the human host response to Leishmania panamensis. Am J Dermatopathol 19: 585-590.
31. Reed SG, Scott P 1993. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 5: 524-531.
32. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM 1998. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31: 143-148.
33. Ridley DS, Marsden PD, Cuba CC, Barreto AC 1980. A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans R Soc Trop Med Hyg 74: 508-514.
34. Rocha PN, Almeida RP, Bacellar O, de Jesus AR, Filho DC, Filho AC, Barral A, Coffman RL, Carvalho EM 1999. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 180: 1731-1734.
35. Scott P, Farrell JP 1998. Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chem Immunol 70: 60-80.
36. Scott P, Natovitz P, Sher A 1986. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J Immunol 137: 1017-1021.
37. Turetz ML, Machado PR, Ko AI, Alves F, Bittencourt A, Almeida RP, Mobashery N, Johnson WD, Carvalho EM 2002. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186: 1829-1834.
38. Uyemura K, Pirmez C, Sieling PA, Kiene K, Paes-Oliveira M, Modlin RL 1993. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J Immunol 151: 7095-7104.
39. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, Laskay T 2004. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 173: 6521-6525.
40. Vieira MGS, Oliveira F, Arruda S, Bittencourt AL, Barbosa Jr AA, Barral-Netto M, Barral A 2002. B-cell infiltration and frequency of cytokine producing cells differ between localized and disseminated human cutaneous leishmaniases. Mem Inst Oswaldo Cruz 97: 979-983.
41. von Stebut E 2007. Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 17: 115-122.
42. Weigle K, Saravia NG 1996. Natural history, clinical evolution and the host-parasite interaction in new world cutaneous leishmaniasis. Clin Dermatol 14: 433-450.
43. Yang HZ, Li Z, Liu HZ, Mi S, Hu ZW 2009. The identification and advances of regulatory B cells. Sheng Li Ke Xue Jin Zhan 40: 297-302.
44. Yoneyama KAG, Peder LD, Lonardoni MVC, Silveira TGV 2007. Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay in patients from northern Paraná state, Brazil. Braz J Infect Dis 11: 360-364.